Cité des Sciences et de l'Industrie


  • Format of your poster: portrait format 80 cm width x 120 cm high,
  • Install your poster between 7h00 and 8h30 the day indicated on the matching sign,
  • Your presence is required near your poster during the poster session during the break indicated for 45 minutes,
  • Please remove your poster at the end of the day.


The call for abstract is now closed.




With our motto “Innovation for participation” we invite authors from all fields and professions surrounding children with disabilities to submit their topics. Innovation must be understood not as only as technological, but also includes innovation in treatment, interventions, service provision, care systems and models of collaboration with children and their families, with the ultimate aim to increase participation opportunities for all.

All abstracts related to childhood-onset disabilities are welcome, including those on treatment, prevention, early detection, early intervention, transition and lifespan issues, parents’ and siblings’ experiences, adult research, health systems, engineering in disability, basic sciences, social science research and ethics.

We are interested in receiving submissions across a large number of conditions, including cerebral palsy, acquired brain injury (traumatic, stroke, cancer), neuromuscular disorders, musculo-skeletal disorders, obstetrical brachial plexus palsy, spinal disorders, intellectual impairments, learning disabilities, profound intellectual and multiple disabilities, ADHD, autism spectrum disorder, sensory impairments, genetic syndromes (e.g. Down, Rett, …), rare diseases (e.g. neurometabolic, neurodegenerative, …) and all other neurodevelopmental conditions.

The following topics are a non-exclusive list of themes suggested by the scientific committee for free communications :

    • Innovation in treatment :
      • Motor and non-motor interventions (physiotherapy, occupational therapy, speech langage therapy, environnement, …),
      • Technology-assisted rehabilitation (robotics, exergaming, telerehabilitation, …)
      • Assistive devices (for movement, communication, learning, …)
      • Low-cost innovation
      • Surgery (orthopaedic surgery, neurosurgery, …)
      • Service provision
      • Palliative care and pain
      • Gene therapy, stem cell therapy, neuroprotection,
    • Innovation in diagnostics and assessments
      • Brain imagery
      • Neurophysiology
      • Musculo-skeletal imagery, modeling and physiology
      • Movement analysis and biomechanics
      • Measures especially of function and participation
      • Cognitive and language assessments
      • Deep Learning and Big data
    • Enhancing participation
      • Child and family centered research and care
      • Healthcare models research
      • Epidemiology, registry based research
      • Lifespan perspectives
      • Sports, leisure and community inclusion



Oral presentation sessions: a group of talks within a theme by individual participants. Eight presentations of 10 minutes each (including questions and answers) will be scheduled in parallel sessions of 90 minutes.

Poster sessions: provide opportunity for presenting novel methods and findings and include discussion on-site. Posters will be sorted by theme. Each poster will be on display one full day of the conference and include a dedicated poster session.

Instructional courses: didactic sessions of 90 min in the morning with at least 2 instructors addressing a focused theme or method with appeal to a targeted audience. Examples are new assessments, investigations, techniques, treatments etc. The courses shall be interactive and practical.

Mini symposium: provides a state-of-the-art overview of research evidence and clinical application of a theme that is relevant and innovative. At least 3 presenters with a multidisciplinary background will present in a 90 min session that includes 15 minutes for discussion with the audience. Mini symposia involving stakeholders, including patients and families, and related to the motto of the conference will be favored.




Before you begin with the online abstract form please prepare the following information:

  • Only abstracts following the guidelines will be accepted.
  • The abstract body text is limited to a maximum of 250 words, excluding title and authors. Figures and tables are not allowed.
  • Abstract title (limited to a maximum of 200 characters).
  • Contact details of the main author.
  • Details of author and all co-authors: family name, initial(s), institute, city, country.
  • Preferred presentation type (when entering your abstract data online, you will be asked to indicate one of the below preferences): Oral – Poster – Instructional course – Mini symposium
  • Abstract for oral and poster presentation : Structure your abstract with the following headings: – Introduction – Patients and methods – Results – Conclusion – Please use exactly the lay-out of this format abstract
  • Abstract for instructional course Structure your abstract with the following headings: – Objective – Learning objectives of the course – Target audience – Summary – Outline of the course – Please use exactly the lay-out of this format abstract
  • Abstract for mini symposium : Structure your abstract with the following headings: – Objectives – Summary – Outline of the symposium – Please use exactly the lay-out of this format abstract
  • Please note the deadline of October 31st, 2018. Abstracts arriving after this date will not be accepted.

Abstracts should be submitted via the online submission platform. Mandatory fields are marked with a red asterisk (*).


The Scientific Committee will review the abstracts. The committee will contact authors by January 15th, 2019 at the latest with formal acceptance or rejection notices in order to allow presenters sufficient time to register for the conference and make travel arrangements. All notifications will be sent to the e-mail address provided during the abstract submission process. The number of submissions that can be accepted is limited. Instead of an oral presentation a poster may be advised.



All accepted presenters must register for the conference before the early registration deadline February 15th, 2019. Presenters not registered by this date will not be included in the scientific program.



250 Selected abstracts (oral and poster sessions) will be published in Developmental Medicine & Child Neurology. Following the conference, the selected abstracts will be made publicly available on the DMCN website in pdf-format. All accepted abstracts will be published on the conference website and will be available through a digital app during the conference.



Please do not submit an abstract if you are not confident that you will be able to attend the conference and make the presentation. If your presentation has been accepted but extenuating circumstances prevent your attendance, we ask that you attempt to find another individual to make the presentation and notify us of this change as soon as possible at If cancellation becomes absolutely unavoidable, please contact us immediately at the aforementioned email address so we can remove your presentation from the conference program.



Abstract submission indicates acceptance of and compliance with the rules outlined below:

  • Submission of an abstract constitutes a commitment by the presenting author(s) to attend the conference and present the findings, i.e., that each one of the proposed participants has given his/her consent for the proposal and is committed to participate. If accepted, the presenting author(s) is required to pay all costs associated with the conference.
  • All authors have consented to be included as co-authors, have read and approved the abstract and its contents, and agree with the results stated, that all authors are acknowledged of and agree with the abstract submission rules, and permit the abstract, if accepted, to be published as submitted.
  • The submitting author of an abstract for oral or poster presentation is considered to be the presenting author.
  • The work described is original to the authors and was conducted in accordance with current ethical standards and regulations in biomedical and clinical research.
  • It is expected that all research involving human subjects or animals has been approved by the appropriate ethical review authorities.
  • Abstracts must be unbiased and conflicts of interest shall be disclosed. Papers that are written in a manner that promotes a company, service, or product will not be considered.

For questions and information, please contact

You can also follow the EACD updates @EACDtweet. Everything you need to know about international updates for children with disabilities is there!